General Information of the Compound
| Compound ID |
CP0475115
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-((2-chloro-4-methylphenyl)(2-chlorophenyl)methyl)-3-(1,4,5,6-tetrahydropyrimidin-2-yl)-8-azabicyclo[3.2.1]octan-3-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H29Cl2N3O
|
||||||||||||||||||
| Molecular Weight |
458.433
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(C(N2C3CCC2CC(O)(C3)C2=NCCCN2)c2ccccc2Cl)c(Cl)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H29Cl2N3O/c1-16-7-10-20(22(27)13-16)23(19-5-2-3-6-21(19)26)30-17-8-9-18(30)15-25(31,14-17)24-28-11-4-12-29-24/h2-3,5-7,10,13,17-18,23,31H,4,8-9,11-12,14-15H2,1H3,(H,28,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OGBPNOCDUFGYRD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor